The Academy of Pharmaceutical Sciences

PharMerica achieves 75% generic dispensing rate

PharMerica Corporation announced that the firm leads the long-term care pharmacy industry in generic medication dispensing, with a rate of over 75%. The company's generic dispensing rate is on track to exceed 80% by 2013.

Caraco Pharmaceutical posts $1.2 million 1Q net income, up from $9.4 million net loss last year

Detroit-based Caraco Pharmaceutical Laboratories reported a net income of $1.2 million in the first quarter 2011, which ended June 30.

Bayer's 2nd-quarter profit down 1.3 percent

Germany's Bayer AG saw second-quarter net earnings slip by 1.3 percent as a stronger revenue was offset by one-time charges for lawsuits and writing down a cancer drug.

US sees jump in "pay-for-delay" drug settlements

Brand-name drug companies made a record 21 deals so far this fiscal year with generic firms that delayed production of cheaper generic drugs, the U.S. Federal Trade Commission told lawmakers on Tuesday.

Synta Announces STA-9090 Results Published in Journal a oeBlooda ...

Synta Pharmaceuticals Corp. today announced that results pre-published in the online edition of the journal Blood show that STA-9090 causes degradation of the Wilms' tumor 1 protein and its downstream target proteins, c-Myc and Bcl-2, key factors in acute myeloid leukemia and certain other leukemias; and that treatment with STA-9090 showed strong ...

Branded? Generic? They're Both Doing Great

Which is more impressive: a 21% increase in U.S. sales of a high-margin drug or a 14% increase in U.S. sales of low-margin products? Normally the choice would be clear, but in Teva Pharmaceutical 's case, I'm going to have to go with the slower-but-still-impressive generic drug sales growth.

News and FDA Updates for Caraco

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Colorcon buys Pharmaceutical Coatings Pvt. Ltd.

Colorcon Inc. said Monday that it has bought Pharmaceutical Coatings Pvt. Ltd. of India.

White Paper: Vulnerability In The Tablet Press Rooms

With comprehensive IQ, OQ and PQ's, the pharmaceutical industry has THE MOST stringent quality guidelines in place to ensure product consistency and efficacy.

UPDATE 1-Teva Pharm Q2 profit, sales rise

Teva Pharmaceutical Industries , the world's largest generic drugmaker, reported higher quarterly net profit on Tuesday, boosted by sales of generic medicines and its own branded multiple sclerosis treatment Copaxone.

Teva Earnings Climb on Higher U.S. Drug Sales

TEVA Pharmaceutical Industries Ltd chief executive officer Shlomo Yanai. Photographer: Wolfgang von Brauchitsch/Bloomberg Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited Q2 Profit Beats Estimates, Sales in Line

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended June 30, 2010.

Guru Stocks at 52-Week Low: TM, TEVA, MHS, SYT, YHOO

Guru Stocks at 52-Week Low: Toyota Motor Corp, Teva Pharmaceutical Industries Ltd, Medco Health Solutions Inc, Syngenta AG, Yahoo! Inc.

Elite Pharmaceuticals, Inc. (ELTP) - Financial and Strategic Analysis ...

Elite Pharmaceuticals, Inc. - Financial and Strategic Analysis Review - new company profile and analysis released 2010-07-26 02:17:02 - Elite Pharmaceuticals, Inc.

Patrick J. Zenner Elected to Board of Directors of Par Pharmaceutical Companies, Inc.

Par Pharmaceutical Companies, Inc. today announced that Patrick J. Zenner has been elected to the company's board of directors.

Worldwide strategic alliance for non-chiral chromatography

Novasep and instrAction have entered into an alliance that will offer customers in the pharmaceutical industry a combination of instrAction's proprietary API-selective stationary phases and Novasep's purification capabilities and high performance chromatography technologies.

07/26/10 - LG Health Inks Med Imaging Deal with McKesson

Set to launch its new electronic health initiative by April 2011, Lancaster General Health has signed an enterprise medical imaging agreement with McKesson aimed at improving radiologist and physician workflow and overall patient care.

Cardinal unwraps new apps at annual pow-wow

DENVER Wholesale and health services giant Cardinal Health Friday released a new toolkit for its independent pharmacy customers to help them boost brand identity.

Forest Labs Settles Patent Fight

KGaA recently entered into a patent litigation settlement agreement with about 10 companies that were seeking to launch their generic versions of Alzheimer's drug Namenda .

Mylan Launches the Generic Version of Solodyn , 45 mg, 90 mg and 135 mg Tablets, Announces Settlemen

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Minocycline Hydrochloride Extended Release Tablets , 45 mg, 90 mg and 135 mg, the generic version of Solodyn ER, a treatment for acne, sold by Medicis ...